Study of ALXN2050 in Healthy Adult Participants of Japanese Descent
Clinical trial NCT04952545 · COMPLETED
Trial details
- NCT number
- NCT04952545
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-09
- Primary completion
- 2021-09-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.